Table 2. Results of haplotype analysis in anti-CCP negative RA patients in association with CV events.
Variable | HR (95% CI) | p | |
Age at RA diagnosis (by each year) | 1.08 (1.06–1.10) | <0.001 | |
Hypertension | 0.98 (0.63–1.51) | 0.929 | |
Diabetes mellitus | 1.58 (1.01–2.45) | 0.043 | |
Obesity | 1.22 (0.78–1.89) | 0.390 | |
Dyslipidemia | 1.27 (0.84–1.93) | 0.254 | |
Smoking | 1.12 (0.85–1.48) | 0.417 | |
Haplotypes (rs3134063, rs2073618, rs3134069) | HR (95% CI) * | p * | |
TCA | 1 (reference) | - | |
TGA | 0.94 (0.55–1.60) | 0.825 | |
CCA | 1.09 (0.68–1.76) | 0.724 | |
CGA | 0.54 (0.31–0.95) | 0.032 |
CCP: cyclic citrullinated protein/peptide antibodies; CI: confidence interval; CV: cardiovascular; HR: hazard ratios; RA: rheumatoid arthritis.
*Adjusted for sex, age at RA diagnosis and traditional CV risk factors (hypertension, diabetes mellitus, dyslipidemia, obesity, and smoking habit).